Facebook's Zuckerberg faces Senate hearing but little hope for action

Go back to Facebook's Zuckerberg faces Senate hearing but little hope for action

Oppenheimer Remains Bullish on Facebook (FB) Following Congressional Hearing

April 11, 2018 8:37 AM EDT

Oppenheimer Reiterated an Outperform rating and $225.00 price target on Facebook (NASDAQ: FB) following Mark Zuckerberg's congressional hearing with the Senate Judiciary, Science, Commerce & Transportation committees.

Analyst Jason Helfstein stated that "Mr. Zuckerberg appeared well prepared and delivered his answers in a congenial... More

Facebook (FB) PT Maintained at $242 at JPMorgan; 'Positive on FB Shares... Would be Adding to Positions at Current Levels'

April 10, 2018 6:41 AM EDT

JPMorgan maintained its price target on Facebook (NASDAQ: FB) at $242.00 while maintaining a Overweight rating, ahead of the company's first quarter earnings preview.

Analyst Doug Anmuth notes an upbeat outlook on FB shares, suggesting he would be adding to position at current levels,... More